Clontech Laboratories Releases the ProteoTuner™ Systems

Clontech Laboratories, Inc. has announced the imminent release of its ProteoTuner systems, which will be featured in the April issue of Clontechniques, the company's quarterly newsletter.

Based on work by researchers at Stanford University and licensed from Stanford, the ProteoTuner systems use a technology to regulate the amount of protein of interest present in a cell directly.

According to Clontech, this technique can enable direct manipulation of the in vivo level of a specific protein of interest, making it a powerful tool for analyzing protein function. Because the system has very low toxicity, it is also suitable for animal studies.

"As a long-standing leader in the field of gene expression control, Clontech is proud to add the ProteoTuner systems to its extensive collection of gene and protein control systems, which include the Tet-On® Advanced and Tet-Off® Advanced Inducible Gene Expression systems for gene expression control and the Knockout™ RNAi systems for mRNA knockdown. Each of these three systems has particular, complementary strengths: the tight regulation of the Tet systems, Knockout RNAi's excellent control of endogenous protein levels, and the fast control of protein levels via the ProteoTuner systems. Each can be used independently or combined to enable exquisite control over protein expression," said Carol Lou, General Manager of Clontech Laboratories, Inc.